Latest Grifols News & Updates

See the latest news and media coverage for Grifols. We track all announcements, press releases, and industry mentions in real time, all in one place.

Grifols

Global healthcare company focused on plasma-derived medicines and diagnostics

grifols.com

Headquarters: Sant Cugat del Vallès, Spain
Founded year: 1909
Company type: Public company
Number of employees: 10,000+

Last updated Today

Latest news about Grifols

In short: Grifols achieved a 21.9% profit increase in Q1 2026, refinanced its 2027 debt, and faced scrutiny in Canada over plasma donor safety.

Company announcements

June 11 Grifols

Grifols introduces its 2025-2027 Sustainability Master Plan

The plan is built around six key pillars for responsible practices across the business.

June 3 Grifols

Grifols breaks ground on Spain manufacturing site

The EUR 160 million plant will boost plasma fractionation capacity by three million liters annually.

May 7 Grifols

Grifols shares Q1 results

Results show solid start driven by Biopharma strength, immunoglobulin portfolio, efficiency, refinancing, and strategic projects in Egypt and Canada.

May 7 Grifols

Grifols increases Q1 2026 revenues 3.3% to €1.7 billion

Net profit rises 21.9% to €73 million. Adjusted EBITDA reaches €381 million with stable 22.4% margin. Leverage at 4.3x, liquidity €1.6 billion.

Media coverage

Today MSN

Grifols convenes shareholders with focus on US stock market listing by 2027 after midterms

Grifols convenes its shareholders this Wednesday with a major operation on the table: the stock market listing of its biopharma business in the United States...

June 16 MSN

Norges Bank supports Grifols at its board meeting and CalPERS rejects salaries and re-election of directors

Grifols will hold its shareholders' meeting on June 18. The Catalan company faces the meeting with the support of Norges Bank, although not without discrepancies...

June 15 Intereconomía

Grifols launches in the US a treatment for acute bleeding episodes

The blood derivative company Grifols has launched in the US a fibrinogen concentrate approved by the US health authority -the FDA- for the treatment of...

June 12 Cinco Días

Grifols accelerates in Egypt while receiving signs of interest from a European country for a plasma project

Its Egyptian subsidiary approves an additional investment of 180 million between 2026 and 2029. It will inaugurate in October the first phase of its new factory...

Never miss news about Grifols

Track Grifols and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.